Answers are grounded in this paper and cite their sources.
Policy analysis shows regulatory governance impacts equity in cancer care, implying benefits for health system sustainability.
Keywords: advanced cancer therapies, equity in cancer care, health system sustainability, mission-driven institutions, regulatory governance Citation: Silva-Moreno E (2026) Advanced therapies and cancer policy in Latin America: why regulatory coherence matters more than technological capacity. Front. Public Health 14:1777671. doi: 10.3389/fpubh.2026.1777671 Received: 29 December 2025; Revised: 15 January 2026; Accepted: 21 January 2026; Published: 05 February 2026. Edited by: Reviewed by: Copyright © 2026 Silva-Moreno. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. *Correspondence: Evelyn Silva-Moreno, evelyn.silva@falp.org
No takes yet. Share an insight, caveat, or question.
Evelyn Silva-Moreno (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: